Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population
C Selmi, M De Santis, PM Battezzati, E Generali… - International journal of …, 2020 - Elsevier
Background There is no agreement on the prevalence of anti-phospholipid antibodies
(aPLs) and the correlation with atherosclerosis and cardiovascular (CV) events in the …
(aPLs) and the correlation with atherosclerosis and cardiovascular (CV) events in the …
[HTML][HTML] Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromes
N Vuilleumier, S Pagano, C Combescure… - Journal of clinical …, 2019 - mdpi.com
Autoantibodies against apolipoprotein AI (anti-apoA-I IgGs) are prevalent in atherosclerosis-
related conditions. It remains elusive whether they improve the prognostic accuracy of the …
related conditions. It remains elusive whether they improve the prognostic accuracy of the …
Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome
A Gürlek, Ç Özdöl, G Pamir, I Dinçer… - International heart …, 2005 - jstage.jst.go.jp
To determine whether the presence of anticardiolipin (aCL) antibodies in patients with acute
coronary syndome is predictive of recurrent cardiac events in hospital stay and follow-up …
coronary syndome is predictive of recurrent cardiac events in hospital stay and follow-up …
[HTML][HTML] Low levels of a natural IgM antibody are associated with vein graft stenosis and failure
M Sobel, KI Moreno, M Yagi, TR Kohler, GL Tang… - Journal of vascular …, 2013 - Elsevier
Background All humans have natural, protective antibodies directed against
phosphorylcholine (PC) epitopes, a common inflammatory danger signal appearing at sites …
phosphorylcholine (PC) epitopes, a common inflammatory danger signal appearing at sites …
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
E Nuri, M Taraborelli, L Andreoli, M Tonello… - Immunologic …, 2017 - Springer
Hydroxychloroquine (HCQ) was suggested to play a role in lowering antiphospholipid
antibody titers and preventing thrombotic recurrences in patients with systemic lupus …
antibody titers and preventing thrombotic recurrences in patients with systemic lupus …
[HTML][HTML] Anti-phosphorylcholine IgM, an anti-inflammatory mediator, predicts peripheral vein graft failure: a prospective observational study
M Sobel, M Yagi, K Moreno, TR Kohler, GL Tang… - European Journal of …, 2019 - Elsevier
Objectives One third of infrainguinal vein bypasses may fail within the first 1.5 years. Pro-and
anti-inflammatory mechanisms are thought to be involved in these graft stenoses and …
anti-inflammatory mechanisms are thought to be involved in these graft stenoses and …
Cardiac myosin binding protein-C autoantibodies are potential early indicators of cardiac dysfunction and patient outcome in acute coronary syndrome
TL Lynch IV, DWD Kuster, B Gonzalez… - Basic to Translational …, 2017 - jacc.org
The degradation and release of cardiac myosin binding protein-C (cMyBP-C) upon cardiac
damage may stimulate an inflammatory response and autoantibody (AAb) production. We …
damage may stimulate an inflammatory response and autoantibody (AAb) production. We …
[HTML][HTML] Phosphorylcholine monoclonal antibody therapy decreases intraplaque angiogenesis and intraplaque hemorrhage in murine vein grafts
F Baganha, TJ Sluiter, RCM de Jong… - International Journal of …, 2022 - mdpi.com
Phosphorylcholine (PC) is one of the main oxLDL epitopes playing a central role in
atherosclerosis, due to its atherogenic and proinflammatory effects. PC can be cleared by …
atherosclerosis, due to its atherogenic and proinflammatory effects. PC can be cleared by …
[HTML][HTML] antibodies against MYc-associated Zinc Finger Protein: an independent Marker in acute coronary syndrome?
D Ernst, C Widera, NT Baerlecken… - Frontiers in …, 2017 - frontiersin.org
Introduction Atherosclerosis is considered the pathophysiology underlying cardiovascular
(CVD), cerebrovascular, and peripheral vascular diseases. Evidence supporting an …
(CVD), cerebrovascular, and peripheral vascular diseases. Evidence supporting an …